Logo image of ALCBI.PA

CRYPTO BLOCKCHAIN INDUSTRIES (ALCBI.PA) Stock Fundamental Analysis

EPA:ALCBI - Euronext Paris - Matif - FR0014007LW0 - Common Stock - Currency: EUR

1.065  -0.06 (-4.91%)

Fundamental Rating

2

ALCBI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 100 industry peers in the Software industry. While ALCBI seems to be doing ok healthwise, there are quite some concerns on its profitability. ALCBI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALCBI has reported negative net income.
ALCBI had a negative operating cash flow in the past year.
ALCBI had positive earnings in 4 of the past 5 years.
ALCBI had a positive operating cash flow in 4 of the past 5 years.
ALCBI.PA Yearly Net Income VS EBIT VS OCF VS FCFALCBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

ALCBI has a Return On Assets of -3.64%. This is in the lower half of the industry: ALCBI underperforms 63.00% of its industry peers.
ALCBI's Return On Equity of -5.81% is on the low side compared to the rest of the industry. ALCBI is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
ROA -3.64%
ROE -5.81%
ROIC N/A
ROA(3y)5.57%
ROA(5y)6.39%
ROE(3y)8.04%
ROE(5y)13.19%
ROIC(3y)N/A
ROIC(5y)N/A
ALCBI.PA Yearly ROA, ROE, ROICALCBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

ALCBI's Operating Margin has declined in the last couple of years.
ALCBI's Gross Margin of 69.05% is in line compared to the rest of the industry. ALCBI outperforms 47.00% of its industry peers.
In the last couple of years the Gross Margin of ALCBI has declined.
The Profit Margin and Operating Margin are not available for ALCBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.05%
OM growth 3Y-60.1%
OM growth 5Y-42.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.84%
GM growth 5Y-6.03%
ALCBI.PA Yearly Profit, Operating, Gross MarginsALCBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

ALCBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCBI has more shares outstanding
Compared to 5 years ago, ALCBI has less shares outstanding
Compared to 1 year ago, ALCBI has a worse debt to assets ratio.
ALCBI.PA Yearly Shares OutstandingALCBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1B 2B 3B
ALCBI.PA Yearly Total Debt VS Total AssetsALCBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

ALCBI has an Altman-Z score of 11.20. This indicates that ALCBI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 11.20, ALCBI belongs to the top of the industry, outperforming 91.00% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that ALCBI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.06, ALCBI is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 11.2
ROIC/WACCN/A
WACC8.33%
ALCBI.PA Yearly LT Debt VS Equity VS FCFALCBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

ALCBI has a Current Ratio of 1.41. This is a normal value and indicates that ALCBI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.41, ALCBI perfoms like the industry average, outperforming 58.00% of the companies in the same industry.
ALCBI has a Quick Ratio of 1.19. This is a normal value and indicates that ALCBI is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.19, ALCBI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.19
ALCBI.PA Yearly Current Assets VS Current LiabilitesALCBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for ALCBI have decreased strongly by -236.59% in the last year.
Looking at the last year, ALCBI shows a very negative growth in Revenue. The Revenue has decreased by -25.66% in the last year.
Measured over the past years, ALCBI shows a very strong growth in Revenue. The Revenue has been growing by 49.67% on average per year.
EPS 1Y (TTM)-236.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-126.67%
Revenue 1Y (TTM)-25.66%
Revenue growth 3Y102.2%
Revenue growth 5Y49.67%
Sales Q2Q%-7.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALCBI.PA Yearly Revenue VS EstimatesALCBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALCBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCBI.PA Price Earnings VS Forward Price EarningsALCBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCBI.PA Per share dataALCBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06 0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCBI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRYPTO BLOCKCHAIN INDUSTRIES

EPA:ALCBI (6/27/2025, 7:00:00 PM)

1.065

-0.06 (-4.91%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners78.14%
Ins Owner ChangeN/A
Market Cap279.84M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 71.53
P/FCF N/A
P/OCF N/A
P/B 11.29
P/tB 36.16
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.09
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.64%
ROE -5.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.05%
FCFM N/A
ROA(3y)5.57%
ROA(5y)6.39%
ROE(3y)8.04%
ROE(5y)13.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.79%
ROCE(5y)9.89%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-60.1%
OM growth 5Y-42.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.84%
GM growth 5Y-6.03%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 385.56%
Cap/Sales 11.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.19
Altman-Z 11.2
F-Score2
WACC8.33%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)122.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-236.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-126.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.66%
Revenue growth 3Y102.2%
Revenue growth 5Y49.67%
Sales Q2Q%-7.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-135.69%
EBIT growth 3Y-19.33%
EBIT growth 5Y-14.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-660.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-419.63%
OCF growth 3YN/A
OCF growth 5YN/A